Skip to main content
NCBI home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2004 Dec 15;75(2):348–357. doi: 10.1002/jmv.20277

Reduced nasal IL‐10 and enhanced TNFα responses during rhinovirus and RSV‐induced upper respiratory tract infection in atopic and non‐atopic infants

IJ van Benten 1, CM van Drunen 1,5,✉, JLM Koevoet 1, LP Koopman 2, WCJ Hop 4, ADME Osterhaus 3, HJ Neijens 2, WJ Fokkens 1,5
PMCID: PMC7166991  PMID: 15602724

Abstract

Rhinovirus and respiratory syncytial virus (RSV) are the most prevalent inducers of upper respiratory tract infections (URTI) in infants and may stimulate immune maturation. To estimate the amount of immune stimulation, nasal immune responses were examined during rhinovirus and RSV‐induced URTI in infants. Nasal brush samples were taken from infants (2–26 months; 57% atopic family) with rhinovirus‐induced URTI (N = 20), with RSV‐induced URTI (N = 7), and with rhinovirus‐induced rhinitis (N = 11), from children with asymptomatic rhinovirus infection (N = 7) and from eight non‐infected children. Numbers of nasal brush cells positive for Th1‐, Th2‐, regulatory and proinflammatory cytokines were measured by immunohistochemistry or by measuring protein levels using a cytometric bead array analysis. During rhinovirus and RSV‐induced URTI, fewer regulatory cytokine IL‐10 positive cells were found compared to non‐infected children. This fall was accompanied by an increase in levels of the Th1 cytokine TNFα. IL‐10 responses were inversely related to TNFα responses. No enhanced responses were observed for IFNγ, IL‐12 and IL‐18. Cytokine responses were comparable in children with rhinovirus‐induced URTI and in children with rhinitis, while responses in asymptomatic rhinovirus‐infected children were located between those for symptomatic and asymptomatic rhinovirus‐infected children. Cytokine responses did not depend on the age of the child or atopy in the family. In conclusion, reduced nasal IL‐10 responses during URTI in infants could facilitate the induction of a TNFα response. TNFα in turn could replace the immature production of IL‐12, IL‐18 and IFNγ during URTI to induce an effective clearance of the viral infection and which could stimulate the maturation of Th1 cytokine production in infancy. J. Med. Virol. 75:348–357, 2005. © 2004 Wiley‐Liss, Inc.

Keywords: infant, cytokines, nose, respiratory infection, rhinovirus, RSV

REFERENCES

  1. Akdis CA, Blaser K. 2001. Mechanisms of interleukin‐10‐mediated immune suppression. Immunology 103: 131–136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bartz H, Buning‐Pfaue F, Turkel O, Schauer U. 2002. Respiratory syncytial virus induces prostaglandin E2, IL‐10 and IL‐11 generation in antigen presenting cells. Clin Exp Immunol 129: 438–445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blomqvist S, Roivainen M, Puhakka T, Kleemola M, Hovi T. 2002. Virological and serological analysis of rhinovirus infections during the first two years of life in a cohort of children. J Med Virol 66: 263–268. [DOI] [PubMed] [Google Scholar]
  4. Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JT, Geelen SM, Kimpen JL. 2000. Monocyte IL‐10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one‐year follow‐up study. Am J Respir Crit Care Med 161: 1518–1523. [DOI] [PubMed] [Google Scholar]
  5. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein‐dye binding. Anal Biochem 72: 248–254. [DOI] [PubMed] [Google Scholar]
  6. Brandenburg AH, Groen J, van Steensel‐Moll HA, Claas EC, Rothbarth PH, Neijens HJ, Osterhaus AD. 1997. Respiratory syncytial virus specific serum antibodies in infants under six months of age: Limited serological response upon infection. J Med Virol 52: 97–104. [DOI] [PubMed] [Google Scholar]
  7. Braunstahl GJ, Overbeek SE, Fokkens WJ, Kleinjan A, McEuen AR, Walls AF, Hoogsteden HC, Prins JB. 2001. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 164: 858–865. [DOI] [PubMed] [Google Scholar]
  8. Chalmers IM, Janossy G, Contreras M, Navarrete C. 1998. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood 92: 11–18. [PubMed] [Google Scholar]
  9. Cohen SB, Perez‐Cruz I, Fallen P, Gluckman E, Madrigal JA. 1999. Analysis of the cytokine production by cord and adult blood. Hum Immunol 60: 331–336. [DOI] [PubMed] [Google Scholar]
  10. Corne JM, Lau L, Scott SJ, Davies R, Johnston SL, Howarth PH. 2001. The relationship between atopic status and IL‐10 nasal lavage levels in the acute and persistent inflammatory response to upper respiratory tract infection. Am J Respir Crit Care Med 163: 1101–1107. [DOI] [PubMed] [Google Scholar]
  11. Denny FW, Jr . 1995. The clinical impact of human respiratory virus infections. Am J Respir Crit Care Med 152: S4–S12. [DOI] [PubMed] [Google Scholar]
  12. Feng X, Yau D, Holbrook C, Reder AT. 2002. Type I interferons inhibit interleukin‐10 production in activated human monocytes and stimulate IL‐10 in T cells: Implications for Th1‐mediated diseases. J Interferon Cytokine Res 22: 311–319. [DOI] [PubMed] [Google Scholar]
  13. Garofalo R, Chheda S, Mei F, Palkowetz KH, Rudloff HE, Schmalstieg FC, Rassin DK, Goldman AS. 1995. Interleukin‐10 in human milk. Pediatr Res 37: 444–449. [DOI] [PubMed] [Google Scholar]
  14. Godthelp T, Holm AF, Fokkens WJ, Doornenbal P, Mulder PG, Hoefsmit EC, Kleinjan A, Prens EP, Rijntjes E. 1996. Dynamics of nasal eosinophils in response to a nonnatural allergen challenge in patients with allergic rhinitis and control subjects: A biopsy and brush study. J Allergy Clin Immunol 97: 800–811. [DOI] [PubMed] [Google Scholar]
  15. Groux H. 2001. An overview of regulatory T cells. Microbes Infect 3: 883–889. [DOI] [PubMed] [Google Scholar]
  16. Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG. 2001. Symptom pathogenesis during acute influenza: Interleukin‐6 and other cytokine responses. J Med Virol 64: 262–268. [DOI] [PubMed] [Google Scholar]
  17. Koopman LP, Van Benten IJ, De waal L, Fokkens WJ, Osterhaus ADME, Neijens HJ. 2000. Virus mediated allergy (Vigall)‐study: Study design and clinical results 1 year follow‐up. Am J Respiratory Crit Care Med 161: A347. [Google Scholar]
  18. Lakwijk N, Van Strien RT, Doekes G, Brunekreef B, Gerritsen J. 1998. Validation of a screening questionnaire for atopy with serum IgE tests in a population of pregnant Dutch women. Clin Exp Allergy 28: 454–458. [DOI] [PubMed] [Google Scholar]
  19. Langrish CL, Buddle JC, Thrasher AJ, Goldblatt D. 2002. Neonatal dendritic cells are intrinsically biased against Th‐1 immune responses. Clin Exp Immunol 128: 118–123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lee SM, Suen Y, Chang L, Bruner V, Qian J, Indes J, Knoppel E, van de Ven C, Cairo MS. 1996. Decreased interleukin‐12 (IL‐12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon‐ gamma, natural killer, and lymphokine‐activated killer activity by IL‐ 12 in cord blood mononuclear cells. Blood 88: 945–954. [PubMed] [Google Scholar]
  21. Levings MK, Roncarolo MG. 2000. T‐regulatory 1 cells: A novel subset of CD4 T cells with immunoregulatory properties. J Allergy Clin Immunol 106: S109–S112. [DOI] [PubMed] [Google Scholar]
  22. Makela MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpimaki M, Blomqvist S, Hyypia T, Arstila P. 1998. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol 36: 539–542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Marshall JD, Aste‐Amezaga M, Chehimi SS, Murphy M, Olsen H, Trinchieri G. 1999. Regulation of human IL‐18 mRNA expression. Clin Immunol 90: 15–21. [DOI] [PubMed] [Google Scholar]
  24. Morrison DF, Foss DL, Murtaugh MP. 2000. Interleukin‐10 gene therapy‐mediated amelioration of bacterial pneumonia. Infect Immun 68: 4752–4758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Moulin F, Raymond J, Iniguez JL, Ravilly S, Lebon P, Gendrel D. 1996. Serum alpha‐interferon in lower respiratory tract infections of children. Pediatr Infect Dis J 15: 883–886. [DOI] [PubMed] [Google Scholar]
  26. Noah TL, Henderson FW, Wortman IA, Devlin RB, Handy J, Koren HS, Becker S. 1995. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 171: 584–592. [DOI] [PubMed] [Google Scholar]
  27. Opal SM, DePalo VA. 2000. Anti‐inflammatory cytokines [see comments]. Chest 117: 1162–1172. [DOI] [PubMed] [Google Scholar]
  28. Papadopoulos NG, Stanciu LA, Papi A, Holgate ST, Johnston SL. 2002. A defective type 1 response to rhinovirus in atopic asthma. Thorax 57: 328–332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Piccinni MP. 2002. T‐cell cytokines in pregnancy. Am J Reprod Immunol 47: 289–294. [DOI] [PubMed] [Google Scholar]
  30. Pitkaranta A, Arruda E, Malmberg H, Hayden FG. 1997. Detection of rhinovirus in sinus brushings of patients with acute community‐acquired sinusitis by reverse transcription‐PCR. J Clin Microbiol 35: 1791–1793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Prescott SL, Macaubas C, Holt BJ, Smallacombe TB, Loh R, Sly PD, Holt PG. 1998. Transplacental priming of the human immune system to environmental allergens: Universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 160: 4730–4737. [PubMed] [Google Scholar]
  32. Rainsford E, Reen DJ. 2002. Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation. Br J Haematol 116: 702–709. [DOI] [PubMed] [Google Scholar]
  33. Ribeiro‐do‐Couto LM, Boeije LC, Kroon JS, Hooibrink B, Breur‐Vriesendorp BS, Aarden LA, Boog CJ. 2001. High IL‐13 production by human neonatal T cells: Neonate immune system regulator? Eur J Immunol 31: 3394–3402. [DOI] [PubMed] [Google Scholar]
  34. Rothbarth PH, Habova JJ, Masurel N. 1988. Rapid diagnosis of infections caused by respiratory syncytial virus. Infection 16: 252. [DOI] [PubMed] [Google Scholar]
  35. Sareneva T, Matikainen S, Kurimoto M, Julkunen I. 1998. Influenza A virus‐induced IFN‐alpha/beta and IL‐18 synergistically enhance IFN‐gamma gene expression in human T cells. J Immunol 160: 6032–6038. [PubMed] [Google Scholar]
  36. Sautois B, Fillet G, Beguin Y. 1997. Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood. Exp Hematol 25: 103–108. [PubMed] [Google Scholar]
  37. Schandene L, Alonso‐Vega C, Willems F, Gerard C, Delvaux A, Velu T, Devos R, de Boer M, Goldman M. 1994. B7/CD28‐dependent IL‐5 production by human resting T cells is inhibited by IL‐10. J Immunol 152: 4368–4374. [PubMed] [Google Scholar]
  38. Schultz‐Cherry S, Hinshaw VS. 1996. Influenza virus neuraminidase activates latent transforming growth factor beta. J Virol 70: 8624–8629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sedgwick JD, Riminton DS, Cyster JG, Korner H. 2000. Tumor necrosis factor: A master‐regulator of leukocyte movement. Immunol Today 21: 110–113. [DOI] [PubMed] [Google Scholar]
  40. Shibuya K, Robinson D, Zonin F, Hartley SB, Macatonia SE, Somoza C, Hunter CA, Murphy KM, O'Garra A. 1998. IL‐1 alpha and TNF‐alpha are required for IL‐12‐induced development of Th1 cells producing high levels of IFN‐gamma in BALB/c but not C57BL/6 mice. J Immunol 160: 1708–1716. [PubMed] [Google Scholar]
  41. Shin DI, Banning U, Kim YM, Verheyen J, Hannen M, Bonig H, Korholz D. 1999. Interleukin 10 inhibits TNF‐alpha production in human monocytes independently of interleukin 12 and interleukin 1 beta. Immunol Invest 28: 165–175. [DOI] [PubMed] [Google Scholar]
  42. Strachan DP. 2000. Family size, infection and atopy: The first decade of the “hygiene hypothesis”. Thorax 55 (Suppl 1): S2–S10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Suberville S, Bellocq A, Peguillet I, Lantz O, Stordeur P, Fouqueray B, Baud L. 2001. Transforming growth factor‐beta inhibits interleukin‐10 synthesis by human monocytic cells. Eur Cytokine Netw 12: 141–146. [PubMed] [Google Scholar]
  44. Sung RY, Hui SH, Wong CK, Lam CW, Yin J. 2001. A comparison of cytokine responses in respiratory syncytial virus and influenza A infections in infants. Eur J Pediatr 160: 117–122. [DOI] [PubMed] [Google Scholar]
  45. Tracey KJ, Cerami A. 1993. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 9: 317–343. [DOI] [PubMed] [Google Scholar]
  46. Ukkonen P, Hovi T, von Bonsdorff CH, Saikku P, Penttinen K. 1984. Age‐specific prevalence of complement‐fixing antibodies to sixteen viral antigens: A computer analysis of 58,500 patients covering a period of eight years. J Med Virol 13: 131–148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. van den Biggelaar AH, van Ree R, Rodrigues LC, Lell B, Deelder AM, Kremsner PG, Yazdanbakhsh M. 2000. Decreased atopy in children infected with Schistosoma haematobium: A role for parasite‐induced interleukin‐10. Lancet 356: 1723–1727. [DOI] [PubMed] [Google Scholar]
  48. Vesa S, Kleemola M, Blomqvist S, Takala A, Kilpi T, Hovi T. 2001. Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty‐four months of age. Pediatr Infect Dis J 20: 574–581. [DOI] [PubMed] [Google Scholar]
  49. Wakkach A, Cottrez F, Groux H. 2000. Can interleukin‐10 be used as a true immunoregulatory cytokine? Eur Cytokine Netw 11: 153–160. [PubMed] [Google Scholar]
  50. Williams HC, Forsdyke H, Boodoo G, Hay RJ, Burney PG. 1995. A protocol for recording the sign of flexural dermatitis in children. Br J Dermatol 133: 941–949. [DOI] [PubMed] [Google Scholar]
  51. Yazdanbakhsh M, Kremsner PG, van Ree R. 2002. Allergy, parasites, and the hygiene hypothesis. Science 296: 490–494. [DOI] [PubMed] [Google Scholar]
  52. Zhao Y, Dai ZP, Lv P, Gao XM. 2002. Phenotypic and functional analysis of human T lymphocytes in early second‐ and third‐trimester fetuses. Clin Exp Immunol 129: 302–308. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Virology are provided here courtesy of Wiley

RESOURCES